MARKET

IOVA

IOVA

Iovance Biotherp
NASDAQ
3.700
-0.310
-7.73%
After Hours: 3.790 +0.09 +2.42% 19:59 04/10 EDT
OPEN
3.990
PREV CLOSE
4.010
HIGH
4.310
LOW
3.625
VOLUME
44.59M
TURNOVER
--
52 WEEK HIGH
5.63
52 WEEK LOW
1.639
MARKET CAP
1.52B
P/E (TTM)
-3.3818
1D
5D
1M
3M
1Y
5Y
1D
Iovance Biotherapeutics Is Maintained at Buy by Chardan Capital
Dow Jones · 1d ago
Iovance Biotherapeutics Price Target Maintained With a $16.00/Share by Chardan Capital
Dow Jones · 1d ago
Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE) and Iovance Biotherapeutics (IOVA)
TipRanks · 1d ago
Replimune CRL positive for Iovance in near-term, says Chardan
TipRanks · 1d ago
Iovance could advance 5%-15% on Replimune rejection, says Jefferies
TipRanks · 1d ago
Unusually active option classes on open April 10th
TipRanks · 1d ago
Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback
Seeking Alpha · 5d ago
Weekly Report: what happened at IOVA last week (0330-0403)?
Weekly Report · 5d ago
More
About IOVA
Iovance Biotherapeutics, Inc. is a commercial biotechnology company. The Company is focused on developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. Its products include Amtagvi and Proleukin. Amtagvi is indicated for the treatment of adult patients with melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor, with or without a MEK inhibitor. It is marketing Proleukin (aldesleukin), an interleukin-2 (IL-2) product used in the Amtagvi treatment regimen and in other applications. Amtagvi and Proleukin are part of a treatment regimen that includes lymphodepletion. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings and indications for solid tumor cancers. Its TIL therapy includes melanoma, non-small cell lung cancer and gynecologic cancer.

Webull offers Iovance Biotherapeutics Inc stock information, including NASDAQ: IOVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IOVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IOVA stock methods without spending real money on the virtual paper trading platform.